CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2026)

CollPlant Biotechnologies (CLGN) posted Shares Outstanding (Entity) of $551666.0 for Q4 2022, little changed on a QoQ basis from $554324.0 in Q3 2022, and up 10.68% year-over-year from $498449.0 in Q4 2021.

CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2026) Analysis & Trends

CollPlant Biotechnologies' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $551666.0 for Q4 2022.

  • Quarterly Shares Outstanding (Entity) rose 10.68% year-over-year to $551666.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $551666.0 (up 10.68% YoY) and the FY2022 annual result came in at $551666.0, up 10.68% from the prior year.
  • Shares Outstanding (Entity) was $551666.0 for Q4 2022 at CollPlant Biotechnologies, roughly flat from $554324.0 in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $554324.0 in Q3 2022 and bottomed at $37.0 in Q2 2022.
  • A 5-year average of $328850.3 and a median of $332981.0 in 2020 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2018 — Shares Outstanding (Entity) jumped 64.6% — and 2019, when it rose 1.5%.
  • CollPlant Biotechnologies' Shares Outstanding (Entity) stood at $219229.0 in 2018, then climbed by 13.73% to $249319.0 in 2019, then surged by 38.12% to $344348.0 in 2020, then jumped by 44.75% to $498449.0 in 2021, then climbed by 10.68% to $551666.0 in 2022.
  • Business Quant data shows CLGN's Shares Outstanding (Entity) at $551666.0 in Q4 2022, $554324.0 in Q3 2022, and $37.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 6,012.74 Bn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - 400.00 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 198.10 Mn
10 CollPlant Biotechnologies 4.63 Mn 4.63 Mn -243,000.00 13.75 Mn

Historic Data

Download Data
DateValue
Mar 30, 2026 13.75 Mn
Dec 31, 2025 12.20 Mn
Sep 30, 2025 12.72 Mn
Jun 30, 2025 11.84 Mn
Mar 30, 2025 11.45 Mn
Dec 31, 2024 11.45 Mn
Sep 30, 2024 11.45 Mn
Jun 30, 2024 11.45 Mn
Mar 31, 2024 11.45 Mn
Dec 31, 2023 11.39 Mn
Sep 30, 2023 11.44 Mn
Jun 30, 2023 510.00
Mar 31, 2023 11.27 Mn
Dec 31, 2022 11.03 Mn
Sep 30, 2022 11.09 Mn
Jun 30, 2022 740.00
Mar 31, 2022 10.78 Mn
Dec 31, 2021 9.97 Mn
Sep 30, 2021 10.50 Mn
Jun 30, 2021 760.00